lead position
Trademarks
From seller vetting and proprietary screening technology to brand collaboration and industry partnerships, Temu explains how its intellectual property enforcement programme combats infringement on its marketplace
August 10, 2026
Features list
-
Avoiding the double-filing of trademarks and designs and transferring .EU domain registrations are just two recommendations for IP owners in light of Brexit, as Beverley Potts, David Stone, Joachim Feldges, Keren Livneh and David Shen of Allen & Overy explain -
Following the highly-anticipated UK Supreme Court decision in Warner-Lambert v Generics on plausibility in November 2018, the High Court applied the new plausibility test for the first time in March, as Varuni Paranavitane of AA Thornton explains
-
Charlie Winckworth and Andrew Linch of Cooley look at the controversial provisions of the newly-approved EU Copyright Directive and assess what’s next for the tech companies that will be most affected
-
Sarah Turner, Darren Meale and Adrian Smith of Simmons & Simmons consider what brand owners can do when faced with a bad faith trademark application and how to prepare for a potentially important CJEU decision
-
While the theory around artificial intelligence generates a lot of interest, particularly for trademark specialists, it’s time to assess the potential practical impact on the law, say Lee Curtis and Rachel Platts of HGF
-
Despite the well-known struggles in protecting trademarks and trade secrets in China, there are some tried-and-tested strategies to employ, as Karry Lai and Ellie Mertens hear from in-house counsel at a range of domestic and international companies
Local Insights
Sponsored by
Inspicos
Peter Koefoed of Inspicos examines how the EPO Enlarged Board of Appeal referral G 1/26 could clarify the application of G 1/24 when assessing the allowability of amended patent claims under the EPC
Sponsored by
Maiwald
Alexander Ortlieb, Moritz Kampmann, and Stephan Maidl of Maiwald highlight six EPO appeal decisions that map the absolute floor of what patent applications for AI inventions must disclose – and how spectacularly some applicants miss that mark
Sponsored by
Inventa
Vítor Palmela Fidalgo of Inventa reviews three years of Unified Patent Court jurisprudence, examining emerging approaches to claim interpretation, prosecution history, doctrine of equivalents, and prior use
Sponsored by
Bird & Bird
The singer is among an increasing number of celebrities using trademark law to counter AI-generated impersonation. Ann Henry, Sarah McMullen, and Isabel Humburg of Bird & Bird (Ireland) examine evolving challenges for brand owners
Sponsored by
Inspicos
Nils Byg Jørgensen of Inspicos says a recent EPO decision addresses the extent to which the description and drawings shall be consulted when interpreting claims under European Patent Convention provisions other than patentability
Sponsored by
Inspicos
Jakob Pade Frederiksen of Inspicos provides a status update on the pending case in the lead-up to oral proceedings before the EPO Enlarged Board of Appeal on May 8 2026
Sponsored by
Bird & Bird
Anna Wolters-Höhne of Bird & Bird summarises proposed updates regarding market access activities and explains the practical implications for patentees and potential defendants, with reference to recent Unified Patent Court case law
Sponsored by
NLO
Emily Flood and Gamze Gezer-Voerknecht of NLO examine how European patent law applies to the booming nutraceuticals market, focusing on EPO practice, therapeutic versus non‑therapeutic claims, and strategic drafting considerations
Sponsored by
Patrinos & Kilimiris
Maria Kilimiris of Patrinos & Kilimiris explains a recent decision regarding how genuine use is assessed for trademarks registered across broad categories of goods and their subcategories
Sponsored by
Bird & Bird
Annika Lückemann and Jan van Dieck of Bird & Bird analyse the Unified Patent Court’s opening ruling concerning a supplementary protection certificate, highlighting procedural peculiarities, urgency considerations, and possible implications for pharmaceutical originator-generic disputes